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Abstract
 
Extracts of 
 
Helicobacter pylori 
 
(HP) have been shown to in-
duce leukocyte adhesion in mesenteric venules, but the ef-
fects of HP infection on gastric microvessels are unknown.
Inflammatory cell interactions in the gastric microcircula-
tion were studied by intravital videomicroscopy in mice in-
oculated with either saline or fresh isolates of HP. Platelet
aggregates were detected and quantified in murine portal
blood, while endothelial P-selectin expression was deter-
mined using the dual radiolabeled mAb technique. Platelet
activation and aggregation were studied in HP-infected pa-
tients and controls by measuring the platelet–aggregate ra-
tio and platelet P-selectin expression.
HP infection induced a marked increase in the flux of roll-
ing leukocytes and the appearance of platelet and leukocyte–
platelet aggregates in murine gastric venules. The HP-induced
rolling and platelet aggregate formation was abrogated by
mAbs against L- or P-, but not E- selectin. Endothelial cell
expression of P-selectin was not altered, but platelet P-selec-
tin expression was enhanced in HP-infected mice. Circulat-
ing platelet aggregates and activated platelets were also de-
tected in HP-infected patients. These findings indicate that
platelet activation and aggregation contribute to the mi-
crovascular dysfunction and inflammatory cell recruitment
associated with HP infections. (
 
J. Clin. Invest. 
 
1997. 100:
996–1005.) Key words: platelet activation 
 
• 
 
inflammation 
 
•
 
platelet-leukocyte aggregation 
 
• 
 
peptic ulcers
 
Introduction
 
During the past decade, the gram-negative bacterium 
 
Helico-
bacter pylori
 
 (HP)
 
1
 
 has been identified as one of the most prev-
alent infectious agents in man (1). In addition to its well recog-
nized role as a mediator of gastritis, peptic ulcer, and gastric
neoplasia, HP has also been implicated in the pathogenesis of
cardiovascular diseases (2–4). The latter observations support
the view that HP may exert some of its effects on the gastric
mucosa through an action on the vascular supply.
Several factors have been implicated in the pathogenesis of
HP infection, either dependent on the bacterial strain or on
the host immune response (5). HP may produce substances
that directly injure epithelial cells (6), thereby reducing the re-
sistance of the mucosa to gastric injury. In vitro evidence sug-
gests that HP may also indirectly induce gastric damage by
stimulating epithelial cytokine (mainly IL-8) responses (7).
Furthermore, extracts of HP contain substances that elicit
chemotactic activity in neutrophils and monocytes, and that
can increase the surface expression of some adhesion mole-
cules on isolated granulocytes (8–13). Limited observations in
vivo also support a role for inflammatory cells in the develop-
ment of HP-induced gastric mucosal damage. Two recent stud-
ies in rats that monitored inflammatory cell responses in
mesenteric venules superfused with HP extracts have demon-
strated an enhanced adhesion and emigration of leukocytes,
increased vascular albumin leakage, mast cell degranulation,
and platelet–leukocyte aggregation (12, 14). A weakness of
these studies is that direct exposure of mesenteric venules to
HP extracts may not adequately mimic the inflammatory
events associated with chronic gastric infection.
Recently, a mouse model of HP infection was described
that mimics several aspects of the human disease process (15).
This model affords an opportunity for studies of the in vivo
gastric responses to chronic infection without the need for spe-
cial animal conditions (i.e., germ-free or athymic animals).
This study used this mouse model in an effort to characterize
the inflammatory responses elicited by chronic HP infection in
the gastric microcirculation. For that purpose, we have adapted
the technique of intravital fluorescence microscopy to investi-
gate the effects of chronic HP infection on leukocyte–platelet–
endothelial cell interactions in gastric submucosal venules.
Selectins, in contrast to other adhesion molecules, are re-
stricted to the vascular system where they mediate the initial
attachment of leukocytes to endothelial cells, allowing leuko-
cytes to roll along the venule wall before establishing firm ad-
hesion (16). P-selectin is expressed on the surface of activated
endothelial cells and platelets, in the latter instance contribut-
ing to platelet adhesion and aggregation (17). One of the ma-
jor objectives of this study was to define the contribution of
different leukocyte and endothelial adhesion molecules to the
altered leukocyte and platelet interactions elicited by chronic
HP infection. For that purpose, monoclonal antibodies against
adhesion molecules were used. In addition, the role of selectins
was also examined by measuring endothelial cell expression of
P-selectin in the stomach and other tissues, using the recently
described dual-radiolabeled antibody technique (18). Platelet
P-selectin expression and platelet aggregates were measured
ex vivo in blood from control and HP-infected animals, and
the effects of selectin blockade on aggregate formation were
evaluated. Moreover, platelet aggregates were quantified in
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systemic venous blood of HP-infected and control patients, in
which platelet activation was also assessed by flow cytometry.
 
Methods
 
Bacterial strains.
 
Fresh isolates of 
 
H. pylori
 
 were cultured from bi-
opsy samples of patients with chronic gastritis, with or without a
duodenal ulcer, after previously reported methods (5). In brief, endo-
scopic biopsy samples were taken from the body and antrum, placed
in glass tubes with 0.5 ml of sterile saline, and kept at 4
 
8
 
C for less than
1 h. After homogenization, the samples were gently streaked onto
brain heart infusion agar plates supplemented with Vitox (Oxoid,
Unipath Ltd., Basingstoke, UK), 7% horse blood, and a mixture of
Vancomycin, Trimethoprim, Cefsulodine and Amphotericin B (Ox-
oid), and incubated for 5–8 d at 37
 
8
 
C under microaerophilic condi-
tions. Samples were also processed for fast red-phenol urea and Fer-
gusson’s urea test, and for Gram staining (19). Growing bacteria were
identified as HP based on the morphology of colonies, Gram staining,
and oxidase, catalase, and urease production. Once grown, isolates
were stored at 
 
2
 
70
 
8
 
C (Microbank, Pro-Lab Diagnostics, Ontario,
Canada) for molecular study and subsequent inoculations.
For molecular characterization of the different strains, colonies
were harvested in distilled water, boiled for 10 min, and centrifuged
at 13,000 
 
g
 
 for 1 min. A 25-
 
m
 
l aliquot of the supernatant was used as
the target DNA in amplification assays. The oligonucleotide primers
F1 (5
 
9
 
-GAT AAC AGG CAA GCT TTT GAG G-3
 
9
 
) and B1 (5
 
9
 
-CTG
CAA AAG ATT GTT TGG CAG A-3
 
9
 
) from the HP 
 
cagA
 
 gene,
and V1 (5
 
9
 
-ATT TTA CCT TTT TAC ACA TTC TAG-3
 
9
 
) and V2
(5
 
9
 
-AGA AGC CCT GAG ACC G-3
 
9
 
) from the HP 
 
vacA
 
 gene were
used to amplify a 348-bp and a 396-bp DNA fragment, respectively.
All PCR mixtures contained 50 mM KCl, 20 mM Tris-HCl, 2.5 mM
MgCl
 
2
 
, 0.2 mM of each deoxynucleotide, 0.5 mM of each oligonucle-
otide primer, and 0.5 U of 
 
Taq
 
 polymerase (Boehringer GmbH, Mann-
heim, Germany). Amplifications were performed on a PCR system
9600 thermocycler (Perkin-Elmer Corp., Norwalk, CT) with the fol-
lowing cycling profiles: 94
 
8
 
C for 1 min, 55
 
8
 
C for 1 min, and 72
 
8
 
C for
1 min for 35 cycles, and extension at 72
 
8
 
C for 5 min. The amplified
PCR products were analyzed by agarose gel electrophoresis, stained
with ethidium bromide, and examined under UV light. Negative (dis-
tilled water and 
 
Escherichia coli
 
 ATCC 35218 DNA) and positive
(NCTC 11637 HP strain) controls were included in each experi-
ment (5).
To ascertain which of the strains expressed the vacuolating cyto-
toxin encoded by the 
 
vacA
 
 gene, cytotoxicity assays on HeLa cells
were performed using supernatant proteins from HP concentrated
with a ultrafiltration membrane. Vacuolization was assessed by light
microscopy and defined as positive (Tox
 
1
 
) when it occurred in more
than 50% cells (6).
 
Animal model of H. pylori infection.
 
CD
 
1
 
 mice of both sexes
weighing 25–35 g were obtained from the animal facility of the Uni-
versity of Barcelona, and were housed with a 12-h light dark cycle.
Animals had free access to tap water and food, but were not allowed
to eat for 24 h before each of three treatments, which consisted in oral
gavage with different fresh isolates of HP, according to the methods
described by Marchetti et al. (15). In brief, after an overnight fasting,
mice were given 0.25 ml of a solution of 0.2 M NaHCO
 
3
 
 orally
through a sterile gavage needle to neutralize acidity. After the bicar-
bonate treatment, 10
 
9
 
 CFUs of each strain in 0.15 ml of sterile saline
were administered to each animal through the same route. The same
treatment was repeated after 3 and 5 d. Control groups received the
same amount of saline alone or a suspension of 10
 
9
 
 CFUs of 
 
E. coli
 
ATCC 35218 after the bicarbonate treatment. Infection in a given
mouse was assessed by means of histology, urease test, gram staining
and/or culture of gastric samples obtained at the end of the experi-
ments. Microbiological processing of mice gastric samples was identi-
cal to that described above for human biopsies.
 
Histology.
 
At the end of the experiments, mice were killed by an
overdose of anesthesia, and approximately one-fifth of the gastric tis-
sue, including oxyntic and fundic mucosa, was cut off, fixed in 4%
buffered formalin, and embedded in paraffin; sections (5–7 mm) were
stained with hematoxylin and eosin after standard procedures. Gas-
tritis was graded from 1–5, following the classification described by
Bayerdörffer et al. (9). Infiltration of neutrophils was also graded on
a scale of 1–5, according to the same classification. Each stain was
blindly examined by two pathologists, with an interobserver variabil-
ity of 4%. Intraobserver variability, determined to be 3%, was as-
sessed by reexamining 20% of random samples.
 
Monoclonal antibodies.
 
The mAbs used for the assessment of the
role of adhesion molecules in the mouse model of HP infection were
as follows: RB40.34, a rat IgG1 directed against mouse P-selectin
(20); MEL-14, a rat IgG1 directed against mouse L-selectin (21);
LAM1-116, a mouse IgG2a directed against mouse L-selectin (22);
UZ4, a rat IgM directed against mouse E-selectin (23); M1/70, a rat
IgG2a directed against mouse CD11b (24); and YN-1, a rat IgG2b di-
rected against mouse ICAM-1 (25). In some experiments, P-23, a
nonbinding murine IgG1 directed against human P-selectin (26) was
used as a control mAb. MEL-14 and LAM1-116 were generously pro-
vided by Dr. P. Engel (Duke Medical Center, Durham, NC). UZ4
was generously supplied by Dr. R. Hallmann (Institut für Experimen-
telle Medizin, Erlangen-Nürnberg, Germany), P-23 was produced
and purified by protein A-G chromatography (Pharmacia-Upjohn
Laboratories, Kalamazoo, MI), and YN-1 was produced at Bayer
Laboratories (New Haven, CT). The remaining mAbs were pur-
chased from Pharmingen (San Diego, CA).
For human platelet flow cytometry, the following mAbs, pur-
chased from Immunotech (Marseille, France) were used: phycoeryth-
rin (PE)-conjugated P2, a mouse IgG1
 
k
 
 directed against human
GPIIb-IIIa (CD41a), and FITC-labeled CLB-Thromb/6, a mouse
IgG1 directed against human P-selectin. As a negative control,
679.1Mc7, a mouse FITC-labeled IgG1 was used.
 
Intravital microscopy.
 
Mice were anesthetized with subcutaneous
ketamine (150 mg/kg; Ketalar, Parke-Davies Inc., Morris Klein, NJ)
and xylazine (7.5 mg/kg; Sigma Chemical Co., St. Louis, MO), and the
left carotid artery was cannulated with PE-10 tubing (Portex Ltd.,
Hythe, United Kingdom) to monitor continuously blood pressure and
to administer drugs and mAbs. Throughout the experiments, rectal
temperature was monitored using an electrothermometer, and was
maintained between 36.5 and 37.5
 
8
 
C with an infrared heat lamp. A
midline abdominal incision was made, and the stomach was carefully
externalized, opened along the greater curvature, and the gastric con-
tents were gently removed with a sterile swab. Mice were positioned
on a 20 
 
3
 
 30 cm plexiglas board in a manner that allowed the glandu-
lar portion of the stomach to be placed over a glass slide covering a
3.5 
 
3
 
 3.5 cm hole centered in the plexiglas. The board was mounted
onto the stage of an inverted microscope (Diaphot-300; Nikon,
Tokyo, Japan) with a 
 
3
 
40 objective lens and a 
 
3
 
10 eyepiece to ob-
serve the gastric microcirculation. The fluorescent dye acridine or-
ange (200 
 
m
 
g/ml; Sigma Chemical Co.) was administered intraarteri-
ally to stain leukocytes and platelets (27). The dye was dissolved in
sterile saline and filtered through a 0.22-
 
m
 
m filter (Millipore Corp.,
Molsheim, France). Fluorescence (excitation wavelength, 420–490
nm; emission wavelength, 520 nm) was detected using a CCD camera
model XC-77 (Hamamatsu Photonics, Hamamatsu City, Japan) and a
C2400-60 CCD camera control unit with a C2400-68 intensifier head
(Hamamatsu Photonics) that was attached to the camera. Images
were projected onto a color monitor (Trinitron KX-14CP1; Sony,
Tokyo, Japan), and recorded using a video cassette recorder (BR-
S601MU; JVC, Tokyo, Japan) for off-line analysis. A video date-time
generator (Video Timer; KPM Systems, Barcelona, Spain) displayed
these parameters on recorded and live images.
Submucosal venules with internal diameters between 15 and 20
 
m
 
m were selected for observation. Venular diameter was measured
on-line using a video caliper (Microcirculation Research Institute,
Texas A & M University). The number of adherent and rolling leuko-
cytes and of circulating platelet aggregates was determined off-line
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during playback of videotaped images. Leukocytes were considered
adherent to venular endothelium when stationary for 30 s or longer,
and expressed as number per 100-
 
m
 
m length of venule. Rolling leuko-
cytes were defined as those white blood cells that moved at a velocity
less than that of free-flowing leukocytes in the same vessel. The flux
of rolling leukocytes was measured as the number of rolling leuko-
cytes that passed a fixed point within a small (10-
 
m
 
m) viewing area of
the vessel in a 1-min period, using the same area throughout the ex-
periment. Platelet aggregates were seen as large irregularly shaped
fluorescent structures with changing morphology, and often included
one or more leukocytes that were identified by their characteristic
nuclear staining. Their flux was determined in the same manner as
that of rolling leukocytes.
After surgery, mice were allowed to stabilize for 15 min before
0.05 ml of the acridine orange solution was administered. Images
from three different venules were recorded for 1 min each. Because
of potential hazards of prolonged fluorescence emission on oxy-radi-
cal generation, illumination periods were restricted to 60 s (28).
Fluorescence intravital microscopy was used to analyze the gas-
tric microcirculation in animals infected with two different strains of
HP. Mice inoculated with a 
 
cagA
 
2 
 
Tox
 
2
 
 strain were studied both at
7 and 14 d after the end of inoculation (five animals each); six animals
infected with a 
 
cagA
 
1
 
 Tox
 
1
 
 strain were studied between the seventh
and the fourteenth day. Control groups included animals inoculated
with nontoxigenic 
 
Escherichia coli
 
 (ATCC 35218) (
 
n
 
 
 
5
 
 5), and mice
receiving only bicarbonate in saline (
 
n
 
 
 
5
 
 6). In some additional
 
cagA
 
1
 
 Tox
 
1
 
 HP-infected animals, after baseline measurements,
mAbs directed against 
 
l
 
-selectin (LAM1-116, 60 
 
m
 
g/mouse; MEL-14,
80 
 
m
 
g/mouse), P-selectin (RB40.34, 10 
 
m
 
g/mouse), E-selectin (UZ4,
200 
 
m
 
g/mouse), ICAM-1 (YN-1, 180 
 
m
 
g/mouse) or CD11b (M1/70, 60
 
m
 
g/mouse) were intraarterially given and measurements were re-
peated after a 5-min period. The concentrations of mAbs used in
these studies have been previously demonstrated to have a blocking
effect (21–25, 29). Administration of LAM1-116 induced a significant
decrease on peripheral blood leukocyte counts (from 6,700
 
6
 
800 to
2,100
 
6
 
60 cells/ml; 
 
P
 
 
 
5
 
 0.001), an effect that was not observed after
the administration of any of the remaining mAbs. Platelet counts
were unmodified by the mAbs used in these studies.
 
Endothelial P-selectin expression.
 
The effects of gastric coloniza-
tion of HP on the expression of endothelial P-selectin were assessed
using the dual-radiolabeled mAb technique (18). In brief, RB40.34,
the mAb directed against mouse P-selectin, was labeled with 
 
125
 
I,
whereas the nonbinding mAb P-23 was labeled with 
 
131
 
I. In both in-
stances, the iodogen method was used (30). For that purpose, iodogen
(1,3,4,6-tetrachloro-3
 
a
 
,6
 
a
 
-diphenylglycouril, Sigma Chemical Co.)
was dissolved in chloroform at a concentration of 0.5 mg/ml; 250 
 
m
 
l of
this solution was placed in glass tubes, and chloroform was evapo-
rated under nitrogen. Tubes were kept at 4
 
8
 
C until use. For protein
iodination, 0.2–0.5 ml of 1 mg/ml solution of mAb was incubated in
ice with periodical stirring for 12 min with 1 mCi/mg protein of the
corresponding 
 
125
 
I or 
 
131
 
I iodine. Total volume was brought up to 2.5
ml by adding PBS. Labeled mAbs were recovered from the second
2.5-ml fraction collected when making a gel filtration on G-25 Sepha-
dex column (Pharmacia Fine Chemicals, Uppsala, Sweden), and
stored in 500-
 
m
 
l aliquots at 4
 
8
 
C for up to 3 wk before use.
Mice were anesthetized with subcutaneous ketamine (150 mg/kg)
and xylazine (7.5 mg/kg), and the left carotid artery and femoral vein
were cannulated with PE-10 tubing. A mixture of 10 
 
m
 
g of 
 
125
 
I-Psel
mAb (RB40.34) and 2.5 
 
m
 
g of 
 
131
 
I-nonbinding mAb (P-23) was ad-
ministered through the femoral vein catheter. A blood sample was
obtained through the carotid artery catheter 5 min after injection of
the mAb mixture. The animals were then heparinized (1 mg/kg so-
dium heparin) and rapidly exsanguinated by vascular perfusion of so-
dium bicarbonate buffer via the femoral vein, with simultaneous
blood withdrawal via the carotid artery followed by perfusion of so-
dium bicarbonate buffer via the carotid artery after the inferior vena
cava was severed at thoracic level. Entire organs were harvested and
weighed. 
 
125
 
I (binding mAb) and 
 
131
 
I (nonbinding mAb) activities in
different organs and in 50-
 
m
 
l aliquots of cell-free plasma were
counted in a gamma counter (14800 Wizard 3; Wallac, Turku, Fin-
land), with automatic correction for background activity and spill-
over. The injected activity in each experiment was calculated by
counting a 5-
 
m
 
l sample of the mixture containing the radiolabeled
mAbs. The accumulated activity of each mAb in an organ was ex-
pressed as the percentage of the injected activity per gram of tissue.
P-selectin expression was calculated by subtracting the accumulated
activity of the nonbinding mAb (
 
131
 
I-P-23) from the activity of the
binding anti-P-selectin mAb (
 
125
 
I-RB40.34).
Animals infected with 
 
cagA
 
1
 
 Tox
 
1
 
 HP (
 
n
 
 
 
5
 
 7) and noninfected
animals (
 
n
 
 
 
5
 
 6) were studied. As a positive control, we also studied
the expression of P-selectin in four noninfected animals at 4 h after
the intraperitoneal administration of 
 
Salmonella abortus equi
 
 LPS
(5 mg/kg; Sigma Chemical Co.) (31).
 
Animal platelet activation studies.
 
The presence of circulating ac-
tivated platelets in HP infection in the mouse was assessed by mea-
suring platelet P-selectin expression in total blood from HP-infected
(
 
n
 
 
 
5
 
 5) and control (
 
n
 
 
 
5
 
 5) animals by flow cytometry techniques.
For that purpose, immunolabeling of platelets with mAbs was per-
formed in whole blood using one-color analysis. In brief, 5 
 
m
 
l of
whole blood collected in citrate-phosphate-dextrose (citrate final
concentration 119 nM) with PFA (final concentration 0.3%) were
added to polypropylene tubes preloaded with 50 
 
m
 
l PBS and incu-
bated with saturating concentrations of FITC-conjugated mAbs
(RB40.34 and negative control) in the dark without stirring for 15
min. Samples were then diluted with 1 ml PBS and analyzed with a
FACScan flow cytometer (Becton-Dickinson, Mountain View, CA)
at an excitation wavelength of 488 nm. Fluorescence and scatter sig-
nals were calibrated with 2-
 
m
 
m Calibrite beads (Becton-Dickinson).
FITC fluorescence was detected with a 530/30-nm band pass filter.
Platelets were differentiated from red and white cells by their specific
scatter profile (32); histograms were generated from fluorescence
data obtained in the logarithmic mode from 5.000 events analyzed in
each sample using the LYSYS II 1.1 conversion software (Becton-
Dickinson) in an arithmetic mode (HP 217 computer; Hewlett-Pack-
ard, Palo Alto, CA). An analytical marker was set in the green fluo-
rescence channel so that less than 2% of platelets stained with the
negative control showed fluorescence above this level; this marker
was used as a threshold to determine the proportion of platelets ex-
hibiting immunofluorescence above this level in samples stained with
the anti-P-selectin mAb.
To further study platelet activation in the animal model of HP in-
fection, the presence of circulating platelet aggregates was assessed
by measuring the platelet-aggregate ratio according to the Wu and
Hoak method (33) as modified by Wedzicha et al. (34). In brief, blood
was taken into a vacutainer tube with EDTA containing 0.15%
paraformaldehyde (PFA); an additional blood sample from the same
vein was collected in a similar tube without the addition of PFA. Ag-
gregates present in blood are fixed in the PFA-EDTA mixture, but
are broken up by the high concentration of EDTA in the PFA-free
tube. The platelet-aggregate ratio is given as the ratio of the platelet
count in the PFA-EDTA mixture to that in the EDTA mixture, the
counts having been corrected for packed red cell volume. In the ab-
sence of platelet aggregates, the platelet–aggregate ratio approaches
1.0. Portal venous blood from 
 
cagA
 
1
 
 Tox
 
1
 
 HP-infected (
 
n
 
 
 
5
 
 5) and
control animals (
 
n
 
 
 
5
 
 3) was analyzed. Experiments were performed
in triplicate to minimize sampling errors. The effect of mAbs against
P-, E- and L-selectin on the presence of portal platelet aggregates was
also assessed, using the same doses of mAbs as in the intravital mi-
croscopy studies (four animals each).
 
Human platelet activation studies.
 
The presence of circulating ac-
tivated platelets in HP-infected humans was assessed using systemic
venous blood from HP-positive (
 
n 5 5) and HP-negative (n 5 5) pa-
tients, and by analyzing the samples using the method of Wu and
Hoak as described above (23). Gastric HP infection was assessed by a
commercial urease test (CLOtest; Delta West Ltd., Bently, West
Australia) in patients submitted to diagnostic endoscopy because of
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upper gastrointestinal complaints, and was confirmed by a 14C-urea
breath test (19).
P-selectin expression on platelets in the same population of pa-
tients was studied using flow-cytometric techniques. For that pur-
pose, immunolabeling of platelets with mAbs was performed in
whole blood using dual-color analysis (35, 36). In brief, 5 ml of whole
blood collected in citrate-phosphate-dextrose (citrate final concentra-
tion, 119 nM) with PFA (final concentration, 0.3%) were added to
polypropylene tubes preloaded with 50 ml PBS. Samples for dual-
color analysis were first incubated with saturating concentrations of
anti CD41a-PE in the dark, without stirring, for 15 min at room tem-
perature, followed by the addition of FITC-conjugated mAbs (CLB-
Thromb/6 and negative control) and another incubation for 15 min.
Samples were then diluted with 1 ml PBS, and were analyzed with a
FACScan® flow cytometer at an excitation wavelength of 488 nm.
Fluorescence and scatter signals were calibrated with 2-mm Calibrite
beads. FITC and PE fluorescence were detected with a 530/30- and
575/26-nm band pass filter, respectively, and overlap in the emission
spectra of FITC and PE was corrected. Platelets were differentiated
from red and white cells by their specific anti-CD41a-PE membrane
immunofluorescence; histograms were generated from fluorescence
data obtained in the logarithmic mode from 5.000 events analyzed in
each sample using the LYSYS II 1.1 conversion software in an arith-
metic mode (HP 217 computer; Hewlett-Packard). An analytical
marker was set in the green fluorescence channel so that less than 2%
of platelets stained with the negative control showed fluorescence
above this level; this marker was used as a threshold to determine the
proportion of platelets exhibiting immunofluorescence above this
level in samples stained with the anti-P-selectin mAb.
Statistics. The data were analyzed using standard statistical meth-
ods, i.e., analysis of variance with the Scheffé’s (post-hoc) tests, and
Student’s paired or unpaired t test, where appropriate. All values are
reported as mean values6SEM. Statistical significance was set at P ,
0.05.
All the studies herein reported were conducted according to the
standards of the local Ethical Committee of Hospital Clinic i Provin-
cial of Barcelona.
Results
Bacterial strains and animal model of HP infection. Twelve
different HP strains were isolated and characterized. All the
cagA1 HP strains possessed vacuolating activity on HeLa cells
(which implies expression of the VacA protein), whereas none
of the cagA2 strains induced significant vacuolization. For
that reason, two strains, differing with respect to their cagA
gene and Tox status, were selected for this study. The presence
of both markers significantly (P 5 0.04) influenced the ability
of these two fresh isolates to colonize effectively the mouse
gastric mucosa (70% for cagA1 Tox1 vs. 33% for cagA2
Tox2 strains) when infection was assessed 2 wk after inocula-
tion. At this time, no gross gastric damage was seen, and the
degree of gastritis elicited by HP colonization was moderate
(2.560.13) but significantly (P 5 0.001) higher than that ob-
served in noninfected HP-inoculated animals (1.760.13), E.
coli-inoculated (1.360.2), or saline-treated controls (1.160.1).
The extent of inflammation in HP-infected animals did not
seem to be related to the strain used (2.460.2 for cagA2 Tox2
vs. 2.560.1 for cagA1 Tox1 HP). Infiltrating cells were pre-
dominantly mononuclear; polymorphonuclear leukocytes in
the lamina propria of infected animals were infrequent (, 10%
of infected mice).
Microcirculatory alterations elicited by HP gastric coloniza-
tion. Whereas animals inoculated with saline or E. coli sus-
tained a low flux of rolling leukocytes in gastric venules, this
number was significantly increased in HP-infected animals, ir-
respective of the cagA/Tox status or the duration of infection
(Fig. 1 A and Fig. 2). In animals infected with either cagA1
Tox1 or cagA2 Tox2 HP, the presence of platelet aggregates
circulating within the gastric venules proved to be a character-
istic feature (Fig. 1 B and Fig. 2). In contrast, platelet aggre-
gates were never observed in saline-inoculated animals, and
only in one out of five mice having received E. coli. In neither
control nor infected animals were adherent leukocytes ob-
served.
Circulating aggregates seemed to be fundamentally formed
by platelets, but leukocytes were often identified within them.
To confirm the nature of these aggregates, portal and periph-
eral blood from infected and control animals was obtained,
and extensions were stained with May-Grünwald Giemsa. Fig. 3
is a representative image of portal blood extensions from HP-
infected animals, in which leukocyte–platelet as well as plate-
let–platelet aggregates were identified. Although homotypic
platelet aggregates were also present on systemic venous
blood from the same animals, leukocyte–platelet interactions
were less frequently observed in these samples. Only occasion-
Figure 1. Rolling leukocytes (A) and platelet aggregates (B) circulat-
ing within gastric venules from H. pylori-infected mice. Rolling leu-
kocytes (arrows) were easily identified after acridine orange labeling 
as small round structures circulating at a velocity lower than that of 
free-flowing leukocytes. Platelet aggregates (arrowheads) were seen 
as large circulating structures with changing morphology, and often 
included one or more leukocytes identified by their characteristic nu-
clear staining.
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ally were platelet aggregates identified in blood from control
animals.
Molecular determinants of leukocyte rolling and aggregate
formation. In cagA1 Tox1 HP-infected mice, both P- and
L-selectin blockade resulted in a significant decrease in the
number of rolling leukocytes within the gastric microvessels,
reaching values similar to those of control animals (Fig. 4 A).
This effect contrasts with the lack of effect on this parameter
of the administration of blocking mAbs against E-selectin,
ICAM-1, or CD11b.
In the same group of animals, treatment with a mAb di-
rected against P-selectin was followed by near complete disap-
pearance of platelet aggregates within the gastric microvessels
(Fig. 4 B). In a similar manner, L-selectin blockade resulted in
a significant decrement in the flux of these aggregates (Fig. 4
B). E-selectin does not appear to contribute to this phenome-
non since administration of a blocking dose of an anti-E-selec-
tin mAb had no effect on the number of flowing aggregates
per minute (Fig. 4 B). As expected, neither anti-ICAM-1 nor
anti-CD11b exerted any significant effect in the flux of aggre-
gates. 
Endothelial P-selectin expression. Because P-selectin is
present both in Weibel-Palade bodies from endothelial cells
and a-granules of platelets (16), endothelial P-selectin expres-
sion was assessed taking advantage of the recently described
dual-radiolabeled antibody technique (18). Fig. 5 summarizes
the surface expression of endothelial P-selectin in splanchnic
(Fig. 5 A) and nonsplanchnic vascular beds (Fig. 5 B) in con-
trol and cagA1 Tox1 HP-infected animals, as well as in LPS-
pretreated mice. Infection with HP did not significantly change
the expression of endothelial P-selectin in any of the organs
studied, including the stomach. Conversely, LPS pretreatment
resulted in a 10-fold increase in P-selectin expression in all or-
gans, except for heart and brain (about 25-fold increase) and
kidneys (2.5-fold increase).
Murine platelet activation studies. In mice, cagA1 Tox1 HP
infection was associated to an increase in the platelet surface
expression of the activation marker P-selectin as measured by
flow cytometry (Fig. 6). This fact was accompanied by the
presence of a large number of circulating platelet aggregates,
as reflected by the significantly lower platelet–aggregate ratio
in portal blood from infected animals, relative to control mice
(Fig. 7). In infected animals, administration of a blocking dose
of a mAb against L- or P-selectin (5 min before blood with-
drawal) was followed by complete disappearance of platelet
aggregates in portal blood, as reflected by normalization of the
platelet-aggregate ratio (Fig. 7).
Human platelet activation studies. Since our results in the
mouse model clearly indicate that HP infection induces the
formation of platelet aggregates, we assessed whether this phe-
nomenon also accompanies HP infection in humans. For that
purpose, we analyzed blood samples from patients undergoing
upper gastrointestinal endoscopy. Previous history of diabetes
Figure 2. Flux of rolling leukocytes and platelet aggregates in animals 
inoculated with two different H. pylori strains, E. coli, or saline. Both 
parameters were similar in HP-infected animals, independently of the 
duration of infection or the Tox/cagA status, but higher than those 
observed in E. coli or saline-treated animals (*P , 0.05). Black bars, 
rolling leukocytes (cells/min); striped bars, platelet aggregates (n/min).
Figure 3. Leucocyte–platelet aggre-
gate observed under clear-field mi-
croscopy in a portal blood extension 
from an HP-infected mice. Some 
platelets adherent to the leukocyte 
are completely degranulated
(arrow).
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mellitus, ischemic heart disease, severe pulmonary obstructive
disease, or peripheral arterial disease were excluded in all
cases. Five of the patients (three men and two women) had an
antral or duodenal ulcer with HP colonization, as demon-
strated by CLO test and 14C-urea breath test. The remaining
five patients (two reflux esophagitis, one esophageal diverticle,
one gastric adenocarcinoma, and one normal endoscopic ap-
pearance) were all HP-negative (two men and three women).
Mean age was similar in HP-positive (6463 yr) and HP-nega-
tive (6269 yr) patients.
Although circulating platelet aggregates were not observed
in HP-negative patients (as reflected by an aggregate ratio
close to 1.00) all of the five HP-positive cases did have circulat-
ing aggregates (Fig. 8). To further assess platelet activation in
these patients, surface expression of P-selectin on platelets was
monitored in whole blood by flow cytometry. In agreement
with the platelet aggregate ratio measurements, blood samples
from HP-positive patients exhibited a higher percentage of
P-selectin positive platelets than did HP-negative cases (Fig. 9).
Discussion
During the past few years, there has been a growing body of
evidence that implicates the inflammatory response elicited by
HP colonization as a critical event in the pathophysiology of
gastric ulceration. At the same time, there have been signifi-
cant advances in our understanding of the basic molecular
mechanisms that regulate the trafficking of leukocytes in the
microcirculation. These advances have largely resulted from
the broad application of monoclonal antibodies to techniques
such as flow cytometry and intravital videomicroscopy (37).
Because of the absence of suitable animal models of HP infec-
tion and the complexity of applying intravital microscopic
techniques to solid organs such as the stomach, most of the
Figure 4. Effects of immunoneutralization of adhesion molecules on the flux of rolling leukocytes (A) and platelet aggregates (B) in the gastric 
venules in Tox1 cagA1 HP-infected animals. Results are expressed as mean values from four animals before and five min after the intravenous 
administration of a blocking dose of the corresponding mAb (*P , 0.01). Striped bars, before mAb; black bars, after mAb.
Figure 5. P-selectin expression in endothelium from splanchnic (A) 
and nonsplanchnic (B) organs in animals infected with Tox1 cagA1 
HP (n 5 7) as compared to saline (negative controls; n 5 6) or LPS 
pretreated mice (positive controls, n 5 4). Results are expressed as % 
of total injected dose per gram of tissue (*P , 0.01). Shaded bars, 
control; striped bars, helicobacter; black bars, LPS.
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data related to the mechanisms involved in HP-induced in-
flammation have been obtained using indirect approaches (10–
14). In this regard, acute exposure of the mesenteric microcir-
culation to bacterial filtrates or soluble extracts of HP have
provided a large amount of valuable data. It is not clear, how-
ever, whether the data obtained from mesenteric venules that
are directly exposed to bacterial extracts can be extrapolated
to the responses elicited in gastric mucosal microvessels that
are exposed to the same bacterial products during a state of
chronic infection.
The current work was undertaken to characterize the mi-
crovascular events elicited by gastric HP colonization in a well-
characterized mouse model of HP infection (15, 33). In our
hands, the ability of fresh HP isolates to colonize the mouse
gastric mucosa was dependent on bacterial strain, with cagA1
Tox1 strains having a twofold rate of colonization, relative to
cagA2 Tox2 strains. These results are in keeping with previ-
ously published data (15, 38). The inflammatory response elic-
Figure 6. Analysis of platelet P-selectin surface expression in venous 
blood from HP-infected and control mice. Results are expressed as 
percentage of platelets labeled with a specific mAb against P-selectin 
(*P , 0.05).
Figure 8. Platelet–aggregate ratio as measured by the Wu and Hoak 
method in systemic venous blood from HP2 and HP1 dyspeptic pa-
tients. Similarly to that occurring in mice, HP positivity was signifi-
cantly associated to a lower platelet–aggregate ratio, thus reflecting 
the existence of circulating platelet aggregates (*P , 0.05).
Figure 9. Analysis of platelet P-selectin surface expression in sys-
temic venous blood from HP2 and HP1 patients. Results are ex-
pressed as percentage of platelets labeled with a specific mAb against 
P-selectin (*P , 0.05).
Figure 7. Platelet–aggregate ratio in portal blood from control and 
Tox1 cagA1 HP-infected mice. Whereas in infected animals this pa-
rameter was decreased, reflecting the presence of platelet aggregates, 
the ratio was normalized in infected mice receiving a blocking dose of 
a mAb against P- or L-selectin 5 min before blood sampling (four an-
imals per group; *P , 0.05).
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ited by such colonization was characterized by the presence of
a diffuse mononuclear cell infiltrate, a finding also coincident
with previous published work (15, 38). The similar degree of
inflammation observed in animals infected with cagA1 and
cagA2 strains supports the hypothesis that other factors dis-
tinct from the CagA molecule are responsible for eliciting in-
flammation in the gastric mucosa (38). Our results also con-
firm the existence of marked differences between the human
and mouse inflammatory response, since infiltrating cells are
mainly of the mononuclear type in mice, whereas polymorpho-
nuclear leukocytes predominate in active gastritis in man (9).
Irrespective of the duration of infection or the cagA/Tox
status, HP infection caused a significant increase in the flux of
rolling leukocytes in gastric submucosal venules. This finding,
not previously reported, is in agreement with an increased leu-
kocyte adhesion in mesenteric (12, 14) and submucosal gastric
(39) venules after superfusion of HP extracts. The enhanced
leukocyte rolling is not likely due to differences in shear stress
between control and infected animals since mean arterial
blood pressure, velocity of free-flowing leukocytes, and gastric
mucosal blood flow measured by the hydrogen gas clearance
technique were not decreased (data not shown) in infected
mice. In addition, a possible effect of acridine orange, the fluo-
rescent dye used to stain leukocytes, in leukocyte rolling has
been ruled out in previous studies (27).
Leukocyte–platelet aggregates have been reported to form
in clinical conditions such as respiratory distress, myocardial
infarction, or hemodialysis (17, 40, 41), and in certain experi-
mental models (42), including superfusion of HP extracts on
rat mesenteric (14) and gastric (39) venules. In this paper, we
demonstrate that the formation of platelet aggregates is the
most prominent feature in the gastric microvasculature of mice
infected with HP. This effect seems to be highly specific for HP
infection, since animals challenged with other bacteria exhib-
ited few aggregates (only one out of five mice), that were
never observed in the gastric microvasculature of saline-con-
trol animals. In the animal model of HP infection, the nature
of aggregates is likely mixed, with both homogeneous (plate-
let–platelet) and heterogeneous (leukocyte–platelet) struc-
tures coexisting. Several indirect evidences support this con-
tention: it has been previously shown that superfusion of the
mesentery with HP extracts induces the formation of leuko-
cyte–platelet aggregates, which are easily identified under
clear-field microscopy (14); the aspect of leukocyte–platelet
aggregates elicited by endotoxemia on the mesenteric circula-
tion under fluorescence microscopy is similar to that of aggre-
gates present in gastric microvessels of HP infected mice (per-
sonal observations); L-selectin blockade (LAM 1-116 and
MEL-14) markedly decreases the number of circulating aggre-
gates, this fact implying a direct or indirect participation of leu-
kocytes on their formation; finally, in portal blood extensions
from HP-infected animals both leukocyte–platelet and plate-
let–platelet aggregates were clearly identified. Only the latter,
however, were consistently seen in peripheral blood from in-
fected animals. This fact is probably related to the filtering ef-
fect of pulmonary circulation or to the dynamics of leukocyte–
platelet interactions (40).
In this study, we provide evidence that both leukocyte roll-
ing and the formation of platelet aggregates are dependent on
P- and L-selectin, since blocking mAbs directed against either
of these adhesion molecules resulted in a pronounced reduc-
tion in the flux of rolling leukocytes, and in the presence of ag-
gregates within gastric microvessels (intravital microscopy
studies) and portal blood (normalization of platelet-aggregate
ratio) in HP-infected animals. Both molecules have been im-
plicated in leukocyte rolling in a variety of conditions (21) in
which participation of P-selectin has been supposed to be a
consequence of an enhanced expression of this adhesion mole-
cule by the endothelium. A platelet pathway operating through
P-selectin, however, has recently been shown to mediate leu-
kocyte rolling on high endothelial venules in vivo (43). The in-
hibitory effect of an anti-P-selectin mAb on leukocyte rolling
may hence result from an action on P-selectin expressed either
on platelets, endothelial cells, or both. To ascertain whether
endothelial P-selectin expression was enhanced in animals in-
fected with HP, the dual-radiolabeled antibody technique was
used. We found that HP-infected animals did not exhibit an in-
creased expression of P-selectin in any vascular bed, when
compared to control mice. In contrast, platelet P-selectin ex-
pression in HP-infected mice was significantly enhanced with
respect to that of control animals. The presence of platelet ag-
gregates in portal blood from HP-infected animals and the ab-
rogation of aggregate formation by treatment with an anti-
P-selectin mAb add further support to the contention that HP
infection activates platelets. Although the absolute difference
in platelet–aggregate ratio between infected and control ani-
mals was low, it reflects a large number of circulating aggre-
gates since platelet counts in mice usually exceed 106/ml. The
lack of differences in endothelial P-selectin expression be-
tween infected and control animals argues against a role for
this endothelial molecule in the increased leukocyte rolling
observed in HP infection, suggesting that a platelet P-selectin
operating pathway is involved in this phenomenon. The exist-
ence of constitutive endothelial P-selectin expression in the
gastric vascular network, however, although at a very low
level, does not allow to definitely rule out its contribution to
leukocyte rolling in this setting.
Involvement of P-selectin in the formation of leukocyte–
platelet aggregates could be anticipated, since other authors
previously demonstrated a major role for this adhesion mole-
cule in such interactions (14, 40, 41). A mechanism accounting
for the effects of L-selectin blockade on aggregate formation,
however, is not straightforward. Leukopenia could be respon-
sible, at least in part, for the effect of LAM 1-116, but not for
the effect of MEL-14, on aggregate formation. L-selectin has
been proposed as a ligand for P-selectin (44–46), but some au-
thors disagree (47); others have suggested that both molecules
would be necessary, but neither sufficient to mediate adhesion
by interacting with distinct counterreceptors (48). Alterna-
tively, the possibility exists that platelet activation in the set-
ting of HP infection results from leukocyte-dependent mecha-
nisms, which may be abrogated to some extent by L-selectin
blockade (49).
Because platelet aggregation was a marked and reproduc-
ible phenomenon in the experimental model of HP infection,
we assessed whether platelet activation and aggregation is also
present in systemic venous blood from HP-infected and con-
trol patients. Using two different techniques (flow cytometry
and the Wu and Hoak method), we were able to demonstrate
that platelet activation does indeed occur in human HP infec-
tion. Moreover, the degree of platelet activation seems to be
similar to that reported in other clinical conditions in which
platelet–leukocyte aggregation is thought to play a pathophys-
iological role (17, 40–43, 50).
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The significance of platelet–leukocyte aggregate formation
in HP infection is unknown, but the interaction between both
cell types is considered to be of pathophysiological relevance
in situations such as septic shock, thrombosis, and atheroscle-
rosis (42, 50). There is evidence showing that leukocytes can
activate platelets (49, 51), and that activated platelets can in-
crease the production of superoxide anion (52, 53) or PAF (54)
by leukocytes. Moreover, neutrophils use platelet-derived
arachidonate to increase leukotriene and thromboxane syn-
thesis through P-selectin interactions (55). Since PAF, leuko-
trienes, thromboxane, and other leukocyte and platelet activa-
tion products are known to accumulate in the gastric mucosa
of HP-infected patients (56), it appears reasonable to postulate
that leukocyte–platelet aggregates contribute to the pathogen-
esis of HP-associated gastric damage. In addition, platelet acti-
vation elicited by HP infection might be involved in the pro-
posed association between HP seropositivity and coronary
heart disease (2–4).
In summary, our study provides the first demonstration
that HP infection in mice increases the flux of rolling leuko-
cytes and elicits the formation of platelet aggregates in the gas-
tric microvasculature. Platelet P-selectin expression plays a
major role in the formation of these aggregates, but leukocyte
L-selectin is also involved. In contrast, endothelial P-selectin
expression is not enhanced as a consequence of HP gastric col-
onization. Furthermore, our results provide the first evidence
that platelet aggregates are induced in HP infection in humans.
Activation of human platelets elicited by HP colonization of
the stomach represents a potentially important component of
vascular contribution to the pathophysiology of HP-associated
diseases. 
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